Physician profile
Peter Patrick Blakey
NPI 1659385987
$992.90
in general payments reported to CMS, 2019-2025
17 companies · $101 in 2025
The $101 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $119 · 2021: $132 · 2022: $186 · 2023: $135 · 2024: $81.09 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $253.28 | 2019-2024 | Jornay Pm |
| Corium, LLC | $133.00 | 2022-2025 | Azstarys |
| Tris Pharma INC | $106.76 | 2019-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $104.24 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Kaleo, INC. | $76.14 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.94 | 2020-2025 | Elaprase |
| Sanofi Pasteur INC. | $37.92 | 2019-2020 | |
| Sobi, INC | $35.15 | 2019 | |
| Greer Laboratories, INC. | $30.25 | 2025 | Oralair |
| Adlon Therapeutics L.P. | $30.07 | 2021 | |
| Cranial Technologies, INC | $26.40 | 2019-2020 | |
| Galderma Laboratories, L.P. | $23.42 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $20.56 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.56 | 2021 | |
| Phadia US INC. | $15.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.07 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.79 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Blakey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.